1. Home
  2. DSY vs ANVS Comparison

DSY vs ANVS Comparison

Compare DSY & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$0.34

Market Cap

39.9M

Sector

N/A

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$4.18

Market Cap

111.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
ANVS
Founded
2020
2008
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
111.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DSY
ANVS
Price
$0.34
$4.18
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$13.50
AVG Volume (30 Days)
136.8K
4.0M
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
120.37
N/A
EPS
0.01
N/A
Revenue
$7,323,356.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.43
N/A
Revenue Growth
16.37
N/A
52 Week Low
$0.32
$1.11
52 Week High
$7.33
$6.37

Technical Indicators

Market Signals
Indicator
DSY
ANVS
Relative Strength Index (RSI) 17.67 56.39
Support Level $0.32 $4.12
Resistance Level $0.43 $4.64
Average True Range (ATR) 0.03 0.53
MACD 0.00 -0.11
Stochastic Oscillator 11.25 23.89

Price Performance

Historical Comparison
DSY
ANVS

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: